ASPECCT Trial Updates - Dr. Scott Berry

Description: For more updates visit

Dr. Scott Berry with an update from ECC 2013 on a study of Panitumumab Efficacy and Safety Compared to Cetuximab in Subjects With KRAS Wild-Type Metastatic Colorectal Cancer. (ASPECCT).
Shared By : oncologyeducation
Posted on : 10/07/13
Added : 4 years ago
Category : Colorectal Cancer

More From oncologyeducation

Nothing found.